Abstract
Access to sterile syringes can prevent transmission of blood-borne diseases such as human immunodeficiency virus (HIV) and hepatitis B and C. We conducted a survey of attitudes of pharmacists to aid, in development of the Expanded. Syringe Access Demonstration Program (ESAP) in New York State. ESAP is an HIV prevention initiative that authorizes nonprescription sale of hypodermic needles and syringes by registered pharmacies in New York State beginning January 1, 2001. As part of planning for program implementation, the New York State Department of Health (NYSDOH), in collaboration with the New York State Education Department, conducted a mailed survey of all 4,392 licensed pharmacies in New York State during the summer of 2000. Some surveys (171) were returned as undeliverable. Of the 4,221 eligible respondents, 874 (20.7%) completed surveys were received, of which 574 (65.7%) indicated that their pharmacy would likely participate in ESAP. An additional 11.0% were not sure. Only 139 (15.9%) indicated that they would definitely not participate; 7.4% left this question blank. There were 608 responses to questions on safe disposal practices. Of these, 315 (51.8%) respondents indicated that their pharmacy sold sharps containers, and an additional 29 made them available at no cost. Only 133 (21.9%) respondents to this question did not offer sharps containers and were not interested in doing so. In all, 54 responses indicated that they accepted used hypodernmic needles and syringesfor disposal. Some (170, 28%) that did not accept shaprs for disposal were interested in doing so. More than half (382, 63.0%) did not wish to do so. NYSDOH considered respondent suggestions and minimized ESAP requirements. By March 31, 2001, only 3 months after ESAP became effective, more than half of all licensed pharmacies in New York State were registered for ESAP. Survey results provided useful information to NYSDOH and a good indication of likelihood of registration. The high level of pharmacy participation in ESAP may be reflective of NYSDOH attention to issues raised by pharmacists, as well as the direct effects of outreach to pharmacy chains regarding ESAP.
Keywords: AIDS, HIV, Infection drug use, Pharmacy, Prevention, Substance abuse
Full Text
The Full Text of this article is available as a PDF (182.6 KB).
Footnotes
All of the authors are associated with the AIDS Institute, New York State Department of Health, Albany, New York; Ms. Klein, Ms. Harris-Valente, and Ms. Candelas are with the Division of HIV Prevention, of which Ms. Klein is the Director and Ms. Candelas is with its Bureau of Special Populations; Ms. Radigan and Drs. Narcisse-Pean and Tesoriero are with the Office of Program Evaluation and Research; Dr. Birkhead is Director of the Institute and is also Associate Professor of Epidemiology. School of Public Health, University at Albany, Albany, New York.
References
- 1.Holmberg SD. The estimated prevalence and incidence of HIV in 96 larger US metropolitan areas. Am J Public Health. 1996;86:642–654. doi: 10.2105/AJPH.86.5.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Jarlais DC, Perlis T, Friedman SR, et al. Declining seroprevalence in a very large HIV epidemic: Injecting drug users in New York City, 1991 to 1996. Am J Public Health. 1998;12:1801–1806. doi: 10.2105/AJPH.88.12.1801. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.AIDS Cases by Year of Diagnosis, Includes Inmates, Data as of December 31, 1999. Albany, NY: New York State Department of Health Bureau of HIV/AIDS Epidemiology; 1999. [Google Scholar]
- 4.Smith PF, Milk J, Hyde S, Morse DL. The AIDS epidemic in New York State. Am J Public Health. 1991;81(suppl):54–60. doi: 10.2105/AJPH.81.Suppl.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.AIDS Surveillance Quarterly Update for Cases Reported Through March 2000. Albany, NY: New York State Department of Health, Bureau of HIV/AIDS Epidemiology; 2000. [Google Scholar]
- 6.State of New York. Public Health Law. Book 44, Article 33, Title 7, §33871.
- 7.English T. New York is the latest state to permit over-the-counter sales of syringes and needles in pharmacies. Pharm Today. 2000;6:20–20. [Google Scholar]
- 8.Klein SJ, Birkhead GS, Candelas AR. Expanded syringe access demonstration program in New York State: in intervention to prevent HIV/AIDS transmission. J Urban Health. 2000;77(4):762–767. doi: 10.1007/BF02344036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Linas BP, Coffin PO, Backes G, Vlahov D. New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation. J Urban Health. 2000;77(4):768–780. doi: 10.1007/BF02344037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Coffin PO, Linas BP, Factor SH, Vlahov D. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access. J Urban Health. 2000;77(4):781–793. doi: 10.1007/BF02344038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.DesJarlais DC. Structural interventions to reduce HIV transmission among injecting drug users. AIDS. 14(suppl 1):S41–S46. [DOI] [PubMed]
- 12.Coffin P. Syringe availability as HIV prevention: a review of modalities. J Urban Health. 77(3):306–330. [DOI] [PMC free article] [PubMed]
- 13.American Medical Association. HIV prevention and access to sterile syringes. Joint letter issued by the American Medical Association, American Pharmaceutica Association, Association of Saate and Territorial Health Officials, National Alliance of State and Territorial AIDS Directors, the National Association of Boards of Pharmacy. October, 1999. Available at; www.nastad.org/publicpolicyresources/hivprevsterilesyringes.pdf. Accessed October 10, 2001.
- 14.Taussig J, Weinstein B, Burris S, Jones TS. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US. AIDS. 14(suppl 1):S47–S51. [DOI] [PubMed]